Table 1.
General characteristics and quality assessment of the studies included in this network meta-analysis.
| Treatment group 1 | Treatment group 2 | Ending indicators | |||||
|---|---|---|---|---|---|---|---|
| Inclusion in the study | Interventions | Number of cases (male/female) | Age (years) | Interventions | Number of cases (male/female) | Age (years) | |
| Zhang Lei 2019 | PRP+HA | 42 (18/24) | 56.28 ± 4.36 | HA | 42(16/26) | 57.13 ± 4.89 | ①+② |
| Jiang Li 2016 | HA | 43(27/16) | 65.12 ± 3.12 | HA+OZ | 43(29/14) | 65.83 ± 3.59 | ②+① |
| Li Jun 2020 | PRP | 45(25/20) | 52.09 ± 2.13 | HA | 43(27/18) | 53.24 ± 2.17 | ②+③ |
| Sugar Zi Peng 2020 | PRP | 50(22/28) | 63.49 ± 3.32 | HA | 50(23/27) | 64.27 ± 3.54 | ③ |
| Liao Dehua 2020 | HA | 43(19/24) | 58.3 ± 4.6 | OZ | 44(21/23) | 59.1 ± 4.7 | ②+⑩ |
| HA+OZ | 43(20/23) | 58.7 ± 4.3 | |||||
| Wu Chunxi 2015 | HA+OZ | 118 | HA | 118 | ② | ||
| Li Bao 2020 | HA+OZ | 73(19/54) | 57.2 ± 8.4 | HA | 73(22/51) | 59.6 ± 8.4 | ②+⑧ |
| Chen Ping 2019 | OZ | 54(20/34) | 58.6 ± 3.4 | HA | 54(22/32) | 58.5 ± 3.4 | ② |
| Kong Deguang 2020 | HA+OZ | 115(65/50) | 64.3 ± 6.8 | HA | 115(57/58) | 64.9 ± 7.1 | ②/① |
| Ji Changkun 2020 | PRP | 90(65/25) | 60.9 ± 9.4 | HA | 79(45/34) | 42.5 ± 9.5 | ③+① |
| Li Xiaoyang 2019 | OZ | 30(16/14) | 66.35 ± 6.05 | HA | 30(14/16) | 66.42 ± 6.34 | ②+⑩ |
| Meng Tao 2018 | OZ | 46(21/25) | 61.27 ± 8.31 | HA | 46(20/26) | 61.80 ± 8.26 | ②+① |
| HA+OZ | 46(21/25) | 61.58 ± 8.36 | |||||
| Pan Lutao 2018 | HA+OZ | 64(14/50) | 64.2 ± 6.4 | HA | 64(16/48) | 63.4 ± 5.8 | ②+④ |
| Bo Qimin 2020 | HA+OZ | 68(38/30) | 56.23 ± 3.27 | OZ | 68(36/32) | 57.02 ± 3.19 | ⑨ |
| Lan Pei Li 2012 | HA+OZ | 53(21/32) | 68.59 ± 8.6 | OZ | 40(14/26) | 66.33 ± 7.8 | ②+① |
| Lu Bin 2018 | HA+OZ | 41(23/18) | 59.31 ± 9.37 | HA | 41(25/16) | 58.26 ± 9.61 | ②+④ |
| 41(19/23) | 59.91 ± 9.85 | ||||||
| Cai Lixin 2018 | OZ | 30(16/14) | 66.35 ± 6.05 | HA | 30(14/16) | 66.42 ± 6.34 | ⑨ |
| Ke Xinru 2019 | HA | 43(27/16) | 65.12 ± 3.12 | HA+OZ | 43(29/14) | 65.83 ± 3.59 | ②+① |
| Chen Xiaolong 2013 | HA+OZ | 60(34/26) | 67.15 ± 6.24 | HA | 60(33/27) | 67.48 ± 6.14 | ② |
| Huang Kaihua 2019 | HA | 37(8/29) | 63.16 ± 7.12 | PRP | 33(8/25) | 65.03 ± 7.10 | ⑦ |
| PRP+HA | 31(8/23) | 63 ± 7.02 | |||||
| Liu Buyun 2017 | PRP | 26(6/12) | 59.46 ± 5.93 | HA | 34(8/16) | 61.76 ± 6.76 | ①+② |
| Machi Piao 2018 | PRP | 40(25/15) | 58 ± 8 | HA | 40(24/16) | 59 ± 9 | ②+① |
| Su xianLiang 2020 | PRP | 30(12/18) | 49.02 ± 6.22 | HA | 30(14/16) | 50.01 ± 5.89 | ⑥+③+②+④ |
| Wang Guan Yu 2013 | HA+OZ | 126(34/92) | 56.1 ± 13.7 | HA | 126(44/82) | 51.1 ± 16.7 | ② |
| Xu Bujing 2015 | PRP | 20(6/14) | 51.5 ± 12.9 | HA | 20(7/13) | 52.5 ± 11.9 | ① |
| PRP+HA | 20(5/15) | 52.5 ± 13.0 | |||||
| Cao Jing 2020 | PRP | 50(17/33) | 58.09 ± 3.72 | HA | 50(18/32) | 58.13 ± 3.75 | ⑤ |
| Fu Ligong 2017 | PRP | 33(17/16) | 46.9 ± 7.5 | HA | 34(19/15) | 47.2 ± 7.1 | ① |
| Xiang tai 2020 | PRP | 38(17/21) | 75.01 ± 2.39 | HA | 38(20/18) | 74.39 ± 1.25 | ⑩ |
| Wang Changzheng 2017 | OZ | 100(44/56) | 56.44 ± 5.89 | HA | 100(42/58) | 58.01 ± 6.79 | ②+① |
| Sun Shaoyong 2018 | HA+OZ | 82(48/34) | 59.01 ± 7.81 | HA | 61(32/29) | 58.84 ± 8.02 | ②+① |
| Li Ming 2019 | HA+OZ | 40(25/15) | 59.1 ± 9.9 | HA | 40 (12/28) | 58.4 ± 10.3 | ④+③ |
| Chen Yifei 2020 | PRP | 40 (20/20) | 52.5 ± 2.0 | HA | 40(25/15) | 52.3 ± 2.0 | ① |
| Yu Quan 2017 | HA+0Z | 41(19/22) | 56.7 ± 7.3 | HA | 41(17/24) | 55.9 ± 6.8 | ⑩ |